第5个氟喹诺酮类药品──加替沙星撤市的思考

Thingking from the initiatively recall of Gatiflocaxin, the 5^(th) Fluoroquinolones

通过对抗菌性能良好、并正处于市场旺销之中的加替沙星因诱发严重糖代谢紊乱不良反应而由生产企业主动召回一事,阐述几点发人深省的思考。

Gatifloxacin was the 5^th Fluoroquinolones marketed with satisfied antimicrobial activity and productive selling record in the past a few years. However it was initiatively recalled by the pharmaceutical industry in may of 2006 since it was found to induce Dysglycemia in older adults. Comments and deep thinking was stimulated and presented here.